Eledon Pharmaceuticals, Inc. Common Stock
€3.354
EUR
Last updated on --.
24h volume963.19K
24h highest3.4138 EUR
24h lowest3.2852 EUR
24h Price movement+0.26%
ELDN recent prices
24 Hours
+0.26%+€0.0086
30 days
+11.35%+€0.3397
60 days
+42.99%+€1.001
90 days
+47.90%+€1.079
Key data
Previous close3.3454 EUR
Market cap254.91M EUR
Volume963.19K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.85140 EUR
Net income (FY)-67.21M EUR
Revenue (FY)--
Last report dateMay 13, 2026
About Eledon Pharmaceuticals, Inc. Common Stock
HeadquartersIRVINE
Employees (FY)33.00
Net income per employee (FY)-2.04M EUR
Listed onNasdaq
ELDN conversion tables
 |  |
|---|---|
| 0.5 ELDN | 1.677 EUR |
| 1 ELDN | 3.354 EUR |
| 5 ELDN | 16.77 EUR |
| 10 ELDN | 33.54 EUR |
| |
|---|---|
| 0.5 EUR | 0.14908 ELDN |
| 1 EUR | 0.29815 ELDN |
| 5 EUR | 1.490 ELDN |
| 10 EUR | 2.981 ELDN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ELDN is trading at €3.354, +0.26% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ELDN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ELDN is currently trading at €3.354, +0.26% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ELDN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ELDN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ELDN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ELDN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Eledon Pharmaceuticals, Inc. Common Stock's market cap is currently 254.91M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume963.19K
24h highest3.4138 EUR
24h lowest3.2852 EUR
24h Price movement+0.26%
Start trade with ELDN Perpetual
Sign up to trade